These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 33168935)
1. Correction: ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis. Bogucka K; Marini F; Rosigkeit S; Schloeder J; Jonuleit H; David K; Schlackow M; Rajalingam K Cancer Gene Ther; 2021 May; 28(5):543. PubMed ID: 33168935 [No Abstract] [Full Text] [Related]
2. Reevaluation of the Role of Extracellular Signal-Regulated Kinase 3 in Perinatal Survival and Postnatal Growth Using New Genetically Engineered Mouse Models. Soulez M; Saba-El-Leil MK; Turgeon B; Mathien S; Coulombe P; Klinger S; Rousseau J; Lévesque K; Meloche S Mol Cell Biol; 2019 Mar; 39(6):. PubMed ID: 30642949 [TBL] [Abstract][Full Text] [Related]
3. The protein kinase ERK3 is encoded by a single functional gene: genomic analysis of the ERK3 gene family. Turgeon B; Lang BF; Meloche S Genomics; 2002 Dec; 80(6):673-80. PubMed ID: 12504858 [TBL] [Abstract][Full Text] [Related]
4. ERK3/MAPK6 controls IL-8 production and chemotaxis. Bogucka K; Pompaiah M; Marini F; Binder H; Harms G; Kaulich M; Klein M; Michel C; Radsak MP; Rosigkeit S; Grimminger P; Schild H; Rajalingam K Elife; 2020 Apr; 9():. PubMed ID: 32314963 [TBL] [Abstract][Full Text] [Related]
5. Regulation of ERK3/MAPK6 expression by BRAF. Hoeflich KP; Eby MT; Forrest WF; Gray DC; Tien JY; Stern HM; Murray LJ; Davis DP; Modrusan Z; Seshagiri S Int J Oncol; 2006 Oct; 29(4):839-49. PubMed ID: 16964379 [TBL] [Abstract][Full Text] [Related]
6. A novel role for atypical MAPK kinase ERK3 in regulating breast cancer cell morphology and migration. Al-Mahdi R; Babteen N; Thillai K; Holt M; Johansen B; Wetting HL; Seternes OM; Wells CM Cell Adh Migr; 2015; 9(6):483-94. PubMed ID: 26588708 [TBL] [Abstract][Full Text] [Related]
7. Scaffolding by ERK3 regulates MK5 in development. Schumacher S; Laass K; Kant S; Shi Y; Visel A; Gruber AD; Kotlyarov A; Gaestel M EMBO J; 2004 Dec; 23(24):4770-9. PubMed ID: 15538386 [TBL] [Abstract][Full Text] [Related]
8. Germ Line Deletion Reveals a Nonessential Role of Atypical Mitogen-Activated Protein Kinase 6/Extracellular Signal-Regulated Kinase 3. Ronkina N; Schuster-Gossler K; Hansmann F; Kunze-Schumacher H; Sandrock I; Yakovleva T; Lafera J; Baumgärtner W; Krueger A; Prinz I; Gossler A; Kotlyarov A; Gaestel M Mol Cell Biol; 2019 Mar; 39(6):. PubMed ID: 30642948 [TBL] [Abstract][Full Text] [Related]
9. NEAT1/hsa-mir-98-5p/MAPK6 axis is involved in non-small-cell lung cancer development. Wu F; Mo Q; Wan X; Dan J; Hu H J Cell Biochem; 2019 Mar; 120(3):2836-2846. PubMed ID: 29095526 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the atypical MAPK ERK4 and its activation of the MAPK-activated protein kinase MK5. Kant S; Schumacher S; Singh MK; Kispert A; Kotlyarov A; Gaestel M J Biol Chem; 2006 Nov; 281(46):35511-9. PubMed ID: 16973613 [TBL] [Abstract][Full Text] [Related]
11. The atypical MAPK ERK3 controls positive selection of thymocytes. Sirois J; Daudelin JF; Boulet S; Marquis M; Meloche S; Labrecque N Immunology; 2015 May; 145(1):161-9. PubMed ID: 25521218 [TBL] [Abstract][Full Text] [Related]
12. Glycoproteomic Approach Identifies KRAS as a Positive Regulator of CREG1 in Non-small Cell Lung Cancer Cells. Clark DJ; Mei Y; Sun S; Zhang H; Yang AJ; Mao L Theranostics; 2016; 6(1):65-77. PubMed ID: 26722374 [TBL] [Abstract][Full Text] [Related]
13. A Ras destabilizer KYA1797K overcomes the resistance of EGFR tyrosine kinase inhibitor in KRAS-mutated non-small cell lung cancer. Park J; Cho YH; Shin WJ; Lee SK; Lee J; Kim T; Cha PH; Yang JS; Cho J; Min DS; Han G; Lee HY; Choi KY Sci Rep; 2019 Jan; 9(1):648. PubMed ID: 30679620 [TBL] [Abstract][Full Text] [Related]
14. A functional link between the human cell cycle-regulatory phosphatase Cdc14A and the atypical mitogen-activated kinase Erk3. Hansen CA; Bartek J; Jensen S Cell Cycle; 2008 Feb; 7(3):325-34. PubMed ID: 18235225 [TBL] [Abstract][Full Text] [Related]
15. Nuclear export of ERK3 by a CRM1-dependent mechanism regulates its inhibitory action on cell cycle progression. Julien C; Coulombe P; Meloche S J Biol Chem; 2003 Oct; 278(43):42615-24. PubMed ID: 12915405 [TBL] [Abstract][Full Text] [Related]
16. ERK3 is a constitutively nuclear protein kinase. Cheng M; Boulton TG; Cobb MH J Biol Chem; 1996 Apr; 271(15):8951-8. PubMed ID: 8621539 [TBL] [Abstract][Full Text] [Related]
17. Activation of MK5/PRAK by the atypical MAP kinase ERK3 defines a novel signal transduction pathway. Seternes OM; Mikalsen T; Johansen B; Michaelsen E; Armstrong CG; Morrice NA; Turgeon B; Meloche S; Moens U; Keyse SM EMBO J; 2004 Dec; 23(24):4780-91. PubMed ID: 15577943 [TBL] [Abstract][Full Text] [Related]
18. Ablation of insulin receptor substrates 1 and 2 suppresses Xu H; Lee MS; Tsai PY; Adler AS; Curry NL; Challa S; Freinkman E; Hitchcock DS; Copps KD; White MF; Bronson RT; Marcotrigiano M; Wu Y; Clish CB; Kalaany NY Proc Natl Acad Sci U S A; 2018 Apr; 115(16):4228-4233. PubMed ID: 29610318 [TBL] [Abstract][Full Text] [Related]
19. Knockdown of long non-coding RNA TTTY15 protects cardiomyocytes from hypoxia-induced injury by regulating let-7b/MAPK6 axis. Xie X; Ji Q; Han X; Zhang L; Li J Int J Clin Exp Pathol; 2020; 13(8):1951-1961. PubMed ID: 32922590 [TBL] [Abstract][Full Text] [Related]
20. Propofol protects against hepatic ischemia/reperfusion injury via miR-133a-5p regulating the expression of MAPK6. Hao W; Zhao ZH; Meng QT; Tie ME; Lei SQ; Xia ZY Cell Biol Int; 2017 May; 41(5):495-504. PubMed ID: 28198596 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]